
Granules India Limited has informed the Exchange regarding a press release dated August 20, 2024, titled "Granules India Limited Receives ANDA Approval for Glycopyrrolate Oral Solution ".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated August 20, 2024, titled "Granules India Limited Receives ANDA Approval for Glycopyrrolate Oral Solution ".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India